Hôpital Maisonneuve-Rosemont is a hospital in Montreal, Quebec, Canada, located in the boroughs of Rosemont–La Petite-Patrie and Mercier-Hochelaga-Maisonneuve. It serves the eastern part of the city and offers 800 beds. It employs 5,000 people and 3,000 students annually.

There are 800 beds in Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie.

During the past decade, Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (1 trials), "Relapsing Multiple Sclerosis" (1 trials) and "Relapsing-remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie" in a lesser frequency.

Most popular intervention types in "Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "3APS" (1 trials), "ELND005" (1 trials), "ELND005 (scyllo-inositol)" (1 trials), "Fingolimod 0.5 mg" (1 trials) and "Fingolimod 1.25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".